EQUITY RESEARCH MEMO
Seascape Clinical
Generated 5/11/2026
Executive Summary
Conviction (model self-assessment)60/100
Seascape Clinical is a digital health company that provides ClinOps Pro, a clinical operations automation platform designed for small to mid-sized pharmaceutical and biotechnology sponsors. The platform automates and standardizes sponsor oversight of clinical trials conducted by Contract Research Organizations (CROs), addressing a critical pain point in drug development. By increasing oversight quality, reducing workload, and enabling scalable trial portfolio management, Seascape Clinical helps sponsors maintain control and efficiency without adding headcount. Founded in 2018 and based in San Diego, the company targets a growing market where many sponsors rely on CROs but lack robust tools for oversight.
Upcoming Catalysts (preview)
- Q1 2027Strategic Partnership with Major CRO40% success
- Q3 2026New AI-Driven Analytics Module60% success
- Q4 2026Series A Funding Announcement70% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)